What Is the Best Initial Empirical Treatment of Suspected Sepsis in a Newborn Readmitted Soon after Discharge Home in an Era of Increased Resistance to Antibiotics? A Report of Two Cases

Abstract

Background Colonization/infection by antibiotic-resistant bacteria is becoming a major threat to health care systems.

Case report Two septic neonates were readmitted in our hospital few days after hospital discharge. In both of them, microbiological workup revealed an infection caused by multiresistant pathogens. Noteworthy, one baby had received intensive care management for 4 weeks, whereas the other had been vaginally delivered and sent home on his second day of life.

Conclusion These cases suggest that in countries and/or hospital with high prevalence of colonization/infection by resistant pathogens in nurseries, neonatal intensive care units, and obstetric wards, the choice of initial therapy of suspected sepsis in a neonate readmitted from home soon after discharge should take into account the possibility of an infection due to a multiresistant pathogen.

Keywords

antibiotic-resistant pathogen - neonate - suspected sepsis - initial empirical treatment

• References

• 1 Munoz-Price LS, Poirel L, Bonomo RA. , et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13 (09) 785-796
• 2 European Centers for Disease Control. Annual epidemiological report antimicrobial resistance and healthcare-associated infections 2014. Available at: http://ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=1292 . Accessed May 27, 2016
• 3 Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL. ; European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill 2015; 20 (45) 30062
• 4 Djahmi N, Dunyach-Remy C, Pantel A, Dekhil M, Sotto A, Lavigne JP. Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries. Biomed Res Int 2014; 2014: 305784
• 5 Logan LK, Renschler JP, Gandra S, Weinstein RA, Laxminarayan R. ; Centers for Disease Control; Prevention Epicenters Program. Carbapenem-resistant Enterobacteriaceae in children, United States, 1992–2012. Emerg Infect Dis 2015; 21 (11) 2014-2021
• 6 Nordmann P. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mal Infect 2014; 44 (02) 51-56
• 7 Thaden JT, Lewis SS, Hazen KC. , et al. Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol 2014; 35 (08) 978-983
• 8 Petrosillo N, Giannella M, Lewis R, Viale P. Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art. Expert Rev Anti Infect Ther 2013; 11 (02) 159-177
• 9 Zavascki AP, Bulitta JB, Landersdorfer CB. Combination therapy for carbapenem-resistant Gram-negative bacteria. Expert Rev Anti Infect Ther 2013; 11 (12) 1333-1353
• 10 Roberts JK, Stockmann C, Constance JE. , et al. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants. Clin Pharmacokinet 2014; 53 (07) 581-610
• 11 Simon A, Tenenbaum T. Surveillance of multidrug-resistant Gram-negative pathogens in high-risk neonates—does it make a difference?. Pediatr Infect Dis J 2013; 32 (04) 407-409
• 12 Ministero della Salute Dipartimento della Sanità Pubblica e dell'Innovazione. Circolare “Sorveglianza, e controllo delle infezioni da batteri produttori di carbapenemasi (CPE)”. Available at: http://www.sanfilipponeri.roma.it/cio/pdf/Comunicazioni/Circ.Min%20Sorveglianza%20CPE26-02-2013.pdf . Accessed February 26, 2013
• 13 European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Vers. 6.0, 2016. Available at: http://www.eucast.org . Accessed May 27, 2016
• 14 Maltezou HC, Kontopidou F, Katerelos P, Daikos G, Roilides E, Theodoridou M. Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children. Pediatr Infect Dis J 2013; 32 (04) e151-e154
• 15 Logan LK. Carbapenem-resistant enterobacteriaceae: an emerging problem in children. Clin Infect Dis 2012; 55 (06) 852-859
• 16 Folgori L, Livadiotti S, Carletti M. , et al. Epidemiology and clinical outcomes of multidrug-resistant, gram-negative bloodstream infections in a European tertiary pediatric hospital during a 12-month period. Pediatr Infect Dis J 2014; 33 (09) 929-932
• 17 Giuffrè M, Bonura C, Geraci DM. , et al. Successful control of an outbreak of colonization by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae sequence type 258 in a neonatal intensive care unit, Italy. J Hosp Infect 2013; 85 (03) 233-236
• 18 Kofteridis DP, Valachis A, Dimopoulou D. , et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study. J Infect Chemother 2014; 20 (05) 293-297
• 19 Yin XH, Mikamo H, Tamaya T. Nosocomial infectious potency of imipenem-resistant Pseudomonas aeruginosa isolated from obstetric and gynecologic infections. J Infect Chemother 2003; 9 (01) 97-100
• 20 Khatri A, Naeger Murphy N, Wiest P. , et al. Community-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2015; 59 (08) 4375-4378
• 21 Tacconelli E, Cataldo MA, Dancer SJ. , et al; European Society of Clinical Microbiology. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014; 20 (Suppl. 01) 1-55
• 22 European Committee on Antimicrobial Susceptibility Testing (EUCAST). Data from the EUCAST MIC distribution website. Available at: http://www.eucast.org . Accessed May 27, 2016
• 23 Shapiro ED. Fever without localizing signs. In: Long SS, Pickering LK, Prober CG. eds. Principles and Practice of Pediatric Infectious Diseases. Edinburg, United Kingdom: Elsevier; 2012: 114-117
• 24 Nizet V, Klein JO. Bacterial sepsis and meningitisi. In: Wilson CB, Nizet V, Maldonado YA, Remington JS, Klein JO. eds. Remington and Klein's Infectious Diseases of the Fetus and the Newborn Infant. Philadelphia, PA: Elsevier; 2016: 217-271
• 25 Leonard EG, Dobbs K. Postnatal bacterial infections. In: Martin RJ, Fanaroff AA, Walsh MC. eds. Fanaroff and Martin's Neonatal-Perinatal Medicine. Philadelphia, PA: Elsevier; 2015: 734-750
• 26 Harrison GJ. Approach to infections in the fetus and newborn. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ. eds. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Philadelphia, PA: Elsevier; 2014: 877-901
• 27 Kothari C, Gaind R, Singh LC. , et al. Community acquisition of β-lactamase producing Enterobacteriaceae in neonatal gut. BMC Microbiol 2013; 13: 136
• 28 Chan GJ, Lee AC, Baqui AH, Tan J, Black RE. Risk of early-onset neonatal infection with maternal infection or colonization: a global systematic review and meta-analysis. PLoS Med 2013; 10 (08) e1001502
• 29 Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002; 8 (06) 321-331
• 30 Cardoso T, Almeida M, Friedman ND. , et al. Classification of healthcare-associated infection: a systematic review 10 years after the first proposal. BMC Med 2014; 12: 40
• 31 Manzoni P, De Luca D, Stronati M. , et al. Prevention of nosocomial infections in neonatal intensive care units. Am J Perinatol 2013; 30 (02) 81-88